Serum phosphate and mortality in patients with chronic kidney disease - Wikidata - awgldk - TriplyDB

Serum phosphate and mortality in patients with chronic kidney disease

Serum phosphate and mortality in patients with chronic kidney disease

http://www.wikidata.org/entity/Q34362715

about

Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate Joint modelling of repeated measurement and time-to-event data: an introductory tutorial.Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease.The Effect of Diet on the Survival of Patients with Chronic Kidney Disease.Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks.VS-501: A NOVEL, NON-ABSORBED, CALCIUM- AND ALUMINUM-FREE, HIGHLY EFFECTIVE PHOSPHATE BINDER DERIVED FROM NATURAL PLANT POLYMER Increased serum alkaline phosphatase and serum phosphate as predictors of mortality after stroke.Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis.Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III.Comorbidity burden at dialysis initiation and mortality: A cohort study.Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.Fibroblast growth factor 23 and Inflammation in CKD Diets for patients with chronic kidney disease, should we reconsider?High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients Con: Phosphate binders in chronic kidney disease Postprandial effects of calcium phosphate supplementation on plasma concentration-double-blind, placebo-controlled cross-over human study.Cardiovascular effects of sevelamer in stage 3 CKD.Phosphate Toxicity in CKD: The Killer among Us Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder.Novel drugs and intervention strategies for the treatment of chronic kidney disease.Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients.Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD?Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Management of natural and added dietary phosphorus burden in kidney disease.Hyperphosphataemia: treatment options.Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis.Novel iron-containing phosphate binders for treatment of hyperphosphatemia.Pro: Should phosphate binders be used in chronic kidney disease stage 3-4?A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.The role of phosphate in kidney disease.The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.

P2860

Q26866263-27BD7603-6A31-4C1F-B376-415A16286534 Q28535055-B3B828AE-4DC7-4971-A777-60308FD30D81 Q30885319-2686B8D1-4DEA-46E7-A962-FB575F005A7C Q33642939-4F7CFDA1-828F-4D4B-8904-681B8B777747 Q33749490-0BC21F93-12FC-4B60-BA11-6FB8FC3EC487 Q34119083-57D6AD55-780E-40FD-8385-F2AF727BD2D6 Q34120727-D994BA88-2054-4313-BE4B-2C91785E98E5 Q34310554-688731A6-C6D7-4375-A0A9-B4284BB8F408 Q34788510-8B1B656C-F30E-47BE-B2E4-C80555D7D71B Q35592504-468353DC-0CF5-40EF-912D-0427F0D56354 Q35857872-23BF3683-8677-48D2-95E3-3D3A2828ABCA Q35953344-6EF2AF88-382F-492D-9B7C-35C91E4AC610 Q36035672-D05CFA8D-F24F-4363-A759-72E0D5F03C11 Q36044367-EF77C5BE-08A9-4FE1-A164-82C1C05DA66B Q36067879-78C51E75-4E97-4EF2-BBC3-207FC2AAFD25 Q36073058-EF8DE186-9702-47A4-B5FD-CF23BA2A9CF8 Q36142874-CC1D10C1-46EF-452B-9DA0-2F7D8C6A5873 Q36497902-49206188-61C2-449E-B90E-DE96E719F931 Q36690749-27857EF5-C470-4BBE-8867-D89AFE55C651 Q36796599-B3EA0F4C-F9D8-438E-9D3B-88D2F0C69DCB Q36965142-5D92673A-4D25-4A53-BD96-234508B4E6D4 Q37034750-6B5E878C-3E1D-4ABE-995D-68EC6711C8FC Q37219043-F31C32A1-45F5-40D9-AECC-6FE0850D2394 Q37621547-888F9047-6903-4B79-BC8D-71580B00CA2F Q37685693-9C4D1B87-C77E-4379-B744-216C879997C6 Q37729792-FA0B9528-41A0-4606-84FE-BFB3526C7599 Q38009044-1AE1EE79-8D59-4A7E-B008-BE699E5F5747 Q38011919-8F56631A-98EC-4C5B-BDB4-0908B8FE3B4B Q38016491-F0E42112-4D35-4032-A06A-C49F645F5F77 Q38086992-1A882233-12BE-4DC0-B9E4-970D39DC1D10 Q38102603-0BD4E1AA-1126-46ED-B507-5884C530AB62 Q38200883-7D057FC6-16FD-4D60-B2B3-65E37D454B7C Q38223280-86D13955-B6DB-4AEC-92A4-642FBC15171C Q38263310-2783DD12-15E4-4483-A9D1-5AF48D9F505F Q38570622-1EE05C31-1C42-4E98-81C6-486A669FFDF6 Q38673170-F41A9DE2-4A9B-4D01-A147-ABA9780F55DF Q38741675-3D4ACAEA-D3A2-4BD3-9E43-5B3E971BB34C Q38745657-64ABB35A-6FE2-4A55-9CBF-D221F2426267 Q38793054-AD5FB37B-BA5F-4868-A635-B9E82C12F0A4 Q38819231-7A513645-A8BD-4EF7-8161-49DD6F2189E4

P2860

Serum phosphate and mortality in patients with chronic kidney disease

http://www.wikidata.org/entity/Q34362715

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serum phosphate and mortality in patients with chronic kidney disease

@ast

Serum phosphate and mortality in patients with chronic kidney disease

@en

Serum phosphate and mortality in patients with chronic kidney disease

@nl

type

label

Serum phosphate and mortality in patients with chronic kidney disease

@ast

Serum phosphate and mortality in patients with chronic kidney disease

@en

Serum phosphate and mortality in patients with chronic kidney disease

@nl

prefLabel

Serum phosphate and mortality in patients with chronic kidney disease

@ast

Serum phosphate and mortality in patients with chronic kidney disease

@en

Serum phosphate and mortality in patients with chronic kidney disease

@nl

P1433

Q34362715-F29D8B27-EB2A-45FB-81E9-41CE3E25106E

P1476

Q34362715-C174F27A-91FF-4CFE-B82F-874F1D5528AE

P2093

Q34362715-179B7247-D7A5-4314-9E92-2FD4C1AF7BD5

Q34362715-3B81220D-9D6A-4902-8390-1A8A7AC9B870

Q34362715-44CECD86-39F4-40AC-99D9-8A9E53771198

Q34362715-662E8EED-6ACE-44BE-86E7-8AB95B3F4291

Q34362715-7ED250F2-DEB6-4EF7-BEC3-1207A6ABB3B1

Q34362715-9BC37DC0-2FDC-479E-8A1B-690C202414FF

Q34362715-9FEF2886-7953-4999-B05B-6A2C28A60A88

Q34362715-BED8B2EC-87DF-45A0-BF91-684AC0406B9A

Q34362715-FDD9D045-8A80-43E3-B4E4-4C7D1931E049

P2860

Q34362715-06000EDF-F081-4938-B190-299BC72FE6B1

Q34362715-19AB24AB-D6F2-4E1C-BF8E-305A0824F533

Q34362715-1FEAF89B-F1B6-4A7B-B888-27E046DF42C3

Q34362715-490F6366-CB01-4166-BD97-33CF5246235B

Q34362715-55CB9875-BAC1-4DE7-B751-094B0145A979

Q34362715-59071342-20F4-4AFA-88F8-59D12EA2B3E6

Q34362715-782C50D4-38BC-432D-BB14-0F6C0E7D50E0

Q34362715-79D93062-575F-4D36-8225-0B845C88DF69

Q34362715-7FF79B92-6C83-48A7-B1A4-395E47193F98

Q34362715-83AD3DB8-9DA9-4E91-86A9-0E2DC3C3A4C3

P304

Q34362715-52B4438E-8AB9-4059-A8FD-185C987F328F

P31

Q34362715-789E126F-3926-4913-88F4-8812DE9F2907

P356

Q34362715-C91FC7D7-E0BA-4F57-8DA5-C661A31B1D97

P433

Q34362715-E776290F-804A-4D76-9738-D16F99E7E432

P478

Q34362715-F405CE90-D5B5-46A4-B5AB-C6CF2DAA3E8F

P50

Q34362715-0FBA0CB6-D7A8-4790-80A7-168203393026

Q34362715-4687DEBC-16FC-4299-BEA1-54D110CF458D

P577

Q34362715-F300A687-71CE-420B-8203-CEC4FDD5C87E

P698

Q34362715-0726DA18-B772-4AA4-A3E8-0FE71A69DAD4

P932

Q34362715-DD30C5EF-A461-4E0A-9B9A-9199DB7E0B9E

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Serum phosphate and mortality in patients with chronic kidney disease

@en

P2093

Beverley Lane

http://www.w3.org/2001/XMLSchema#string

Donal J O'Donoghue

http://www.w3.org/2001/XMLSchema#string

Helen Eddington

http://www.w3.org/2001/XMLSchema#string

Janet Hegarty

http://www.w3.org/2001/XMLSchema#string

Philip A Kalra

http://www.w3.org/2001/XMLSchema#string

Rachel J Middleton

http://www.w3.org/2001/XMLSchema#string

Richard Hoefield

http://www.w3.org/2001/XMLSchema#string

Robert N Foley

http://www.w3.org/2001/XMLSchema#string

Smeeta Sinha

http://www.w3.org/2001/XMLSchema#string

P2860

The emerging role of phosphate in vascular calcification.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Racial and survival paradoxes in chronic kidney disease.

Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis.

Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease.

The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.

Review article: Getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease.

P304

2251-2257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.00810110

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Constantina Chrysochou

P577

2010-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20688884

http://www.w3.org/2001/XMLSchema#string

P932

2994087

http://www.w3.org/2001/XMLSchema#string